Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Ken Research Private Limited | PRODUCT CODE: 1182274

Cover Image

PUBLISHER: Ken Research Private Limited | PRODUCT CODE: 1182274

India Next-Generation Oncology Devices and Solutions Market Outlook to FY'2027

PUBLISHED:
PAGES:
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
Online Access Excel (Single User License)
USD 3500
Online Access PDF (Single User License)
USD 4750
Online Access PDF & Excel (Corporate User License)
USD 9000

Add to Cart

The report provides a comprehensive analysis of the potential of Oncology Device and Solution industry in India. The report covers an overview and genesis of the industry, market size in terms of revenue.

Its market segmentations include By Type, By Region, By Clinical Application, By Application, By End Users, By Test Type; growth enablers and drivers; challenges and bottlenecks; trends driving adoption trends; regulatory framework; end-user analysis, industry analysis, competitive landscape including competition scenario and market shares of major players. The report concludes with future market projections of each market segmentation and analyst recommendation's.

Market Overview

According to Ken Research estimates India Oncology Devices and Solutions Market (Revenue) has grown at a CAGR of 18.2% from FY'17-22 supported by heightened manufacturing innovation and growing disease awareness. The rising medical devices industry is benefiting the growth of the oncology devices market.

India faces a sizable cancer burden, which continues to grow exponentially and is expected to rise to ~ Mn in 2025.

There are around ~ NABL accredited labs in India, where North and South Region have the maximum number of NABL certified Labs.

Key Trends by Market Segment

  • By Clinical Application: In India, amongst all prevalent cancers, the five most common types are breast cancer, lung cancer, oral cancer, stomach cancer and cervical cancer. In India, every four minutes a woman is diagnosed with breast cancer.
  • By Test Type: Laboratory Cancer Diagnostic Tests like Bloods tests, urinanalysis, tumor markers, etc. account for around ~% of the total oncology tests performed in India. Other tests include tests like genetic tests, biopsies, etc.

Competitive Landscape

Future Outlook

India Oncology Devices and Solutions Market (Revenue) is expected to grow at a CAGR of 23.1% from FY'2022-2027 with the oncology devices and solutions market capacity to steadily expand, meeting the underserved and unserved demand

Longer-term investments in the public sector are expected to increase for the current private sector exclusive treatments

Product Code: KR1283

Table Of Contents

1. Executive Summary

  • 1.1 Executive Summary: India Next-Generation Oncology Devices and Solutions Market

2. Country Overview

  • 2.1 India Country Overview
  • 2.2 India Population Overview
  • 2.3 Healthcare Budget in India
  • 2.4 Healthcare Infrastructure in India
  • 2.5 Major NABL accredited Labs in India
  • 2.6 Cancer Prevalence in India
  • 2.7 India Medical Tourism, FY'22

3. India Next-Gen Oncology Devices and Solutions Market Overview

  • 3.1 Industry Cycle of India Oncology Next-Gen Devices and Solutions Market
  • 3.2 Overview of India Oncology Next-Gen Devices and Solutions Market
  • 3.3 Trends in India Oncology Next-Gen Devices and Solutions Market
  • 3.4 Growing Oncology Diagnostic and Treatment Techniques in India

4. Market Segmentation of India Oncology Next-Gen Devices and Solutions Market

  • 4.1 Market Size on the basis of Revenue, FY'17-FY'21
  • 4.2 India Next-Gen Oncology Devices and Solutions Market Segmentation by Type, FY'22
  • 4.3 India Next-Gen Oncology Devices and Solutions Market Segmentation by Region, FY'22
  • 4.4 India Next-Gen Oncology Devices and Solutions Market Segmentation by Clinical Application, FY'22

5. India Next-Gen Oncology Devices Market

  • 5.1 Different Fields of Oncology
  • 5.2 Ecosystem of India Oncology Devices Market
  • 5.3 Value Chain Analysis in India Oncology Devices Market
  • 5.4 Market Sizing Analysis of India Next-Gen Oncology Devices Market, FY'17-FY'22
  • 5.5 Market Segmentation of India Next-Gen Oncology Devices by Technology, FY'22
  • 5.6 Market Segmentation of India Next-Gen Oncology Devices by Application, FY'22
  • 5.7 Market Segmentation of India Next-Gen Oncology Devices by End Users, FY'22
  • 5.8 Competition Analysis: Market Share of major Oncology Devices Players in India
  • 5.9 Cross Comparison of major Oncology Devices Players in India
  • 5.10 India Next-Gen Oncology Devices Market Future Sizing, FY'22-FY'27F
  • 5.11 Market Segmentation of India Next-Gen Oncology Devices by Technology, FY'27F
  • 5.12 Market Segmentation of India Next-Gen Oncology Devices by Application, FY'27F
  • 5.13 Market Segmentation of India Next-Gen Oncology Devices by End Users, FY'27F

6. India Oncology Solutions (Testing) Market

  • 6.1 Cancer Patient Journey and Types of tests
  • 6.2 Market Sizing Analysis of India Oncology Solutions Market, FY'17-FY'22
  • 6.3 Market Segmentation of India Oncology Solutions Market by Test Type, FY'22
  • 6.4 India Oncology Solutions Market Future Sizing, FY'22-FY'27F
  • 6.5 Market Segmentation of India Oncology Solutions Market by Test Type, FY'27F

7. End User Analysis of India Oncology Next-Gen Devices and Solutions Market

  • 7.1 Target customers by type of end users

8. Industry Analysis of India Oncology Next-Gen Devices and Solutions Market

  • 8.1 Regulatory Landscape for Next-Gen Oncology Devices in India
  • 8.2 SWOT Analysis of the Indian Next-Gen Oncology Devices and Solutions Market
  • 8.3 Major Growth Drivers in India Next-Gen Oncology Devices and Solutions Market
  • 8.4 Challenges & Bottle Necks in India Oncology Devices and Solutions Market

9. Impact of Covid-19 on India Oncology Next-Gen Devices and Solutions Market

10. Future Outlook of India Oncology Next-Gen Devices and Solutions Market

  • 10.1 Market Size on the basis of Revenue, FY'22-FY'27
  • 10.2 India Next-Gen Oncology Devices and Solutions market segmentation by Region, FY'2027
  • 10.3 India Next-Gen Oncology Devices and Solutions market segmentation by Type, FY'2027
  • 10.4 India Next-Gen Oncology Devices and Solutions market segmentation by Clinical
  • Application, FY'2027

11. Market Opportunity and Analyst Recommendations

  • 11.1 Way Forward: Future Trends and Technologies to leverage in Strategies: Action Plan

12. Research Methodology

  • 12.1 Market Definitions and Assumptions
  • 12.2 Abbreviations
  • 12.3 Market Sizing Approach
  • 12.4 Consolidated Research Approach
  • 12.5 Research Limitations and Future Conclusion
  • Disclaimer
  • Contact Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!